ENVESTNET ASSET MANAGEMENT INC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$579,265
+21.7%
21,344
+37.8%
0.00%
Q2 2023$476,040
-16.5%
15,486
-2.1%
0.00%
Q1 2023$570,164
+11.6%
15,825
+22.4%
0.00%
Q4 2022$510,855
+1.8%
12,926
+3.4%
0.00%
Q3 2022$502,000
+17.8%
12,498
+23.4%
0.00%
Q2 2022$426,000
+28.3%
10,127
+18.8%
0.00%
Q1 2022$332,000
+31.2%
8,524
+34.3%
0.00%
Q4 2021$253,0006,3480.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders